ArticleBreast cancer research and treatment2014

mTORC1/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanisms.

Kathleen A Wilson-Edell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.